The deal covers the supply of the absorbent over the next six years, with the first shipment due to occur in this quarter.
Related topics: Materials & Formulation
ProMetic BioSciences has signed a $35m supply agreement with a leading European biopharmaceutical company, under which it will provide one of its proprietary affinity adsorbents.
The deal covers the supply of the absorbent over the next six years, with the first shipment due to occur in this quarter.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions